Dr. Basile is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
22 Boston Wharf Rd
Boston, MA 02210- Is this information wrong?
Summary
- Dr. Frank Basile is an oncologist in Boston, MA. He received his medical degree from Rutgers New Jersey Medical School and has been in practice 21 years. He specializes in hematologic oncology and is experienced in lung cancer, multiple myeloma, oncology, lymphoproliferative disorder, and ovarian cancer. He has more than 10 publications and over 100 citings.
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
Boston University Medical CenterResidency, Internal Medicine, 1998 - 2001- Tufts Medical CenterResidency, Pathology-Anatomic and Clinical, 1996 - 1998
Rutgers New Jersey Medical SchoolClass of 1996
Certifications & Licensure
MA State Medical License 2000 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection Start of enrollment: 2006 Jun 01
- Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma Start of enrollment: 2009 Jun 01
- Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 Start of enrollment: 2010 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsAnti-CD38 monoclonal antibody interference with blood compatibility testing: Differentiating isatuximab and daratumumab via functional epitope mapping.Btissam Chami, Makoto Okuda, Morvarid Moayeri, France Pirenne, Yoko Hidaka, Ashok Nambiar, Zhili Song, Olivier Bedel, Bailin Zhang, Joern Hopke, Gejing Deng, Chen Zhu,...> ;Transfusion. 2022 Nov 1
- 4 citationsEffect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of a Single Dose of Oral Ivosidenib in Otherwise Healthy ParticipantsBin Fan, David Dai, Marvin Cohen, Huansheng Xu, Feng Yin, Raj Nagaraja, Michelle Mobilia, Caroline Almon, Frank G. Basile, Hua Yang> ;Clinical Pharmacology in Drug Development. 2021 Jan 1
- 39 citationsPhase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma.Irene M. Ghobrial, Chia Jen Liu, Oksana Zavidij, Abdel Kareem Azab, Rachid Baz, Jacob P. Laubach, Yuji Mishima, Philippe Armand, Nikhil C. Munshi, Frank G. Basile, Mic...> ;American Journal of Hematology. 2019 Nov 1
- Join now to see all
Abstracts/Posters
- Updated Results of a Phase 2 Study of Modified Lenalidomide, Bortezomib, and Dexamethasone (RVd-lite) in Transplant-Ineligible Multiple MyelomaFrank Basile, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- AG-636 for the Treatment of Adults with Advanced Lymphoma: Initiation of a Phase 1 Clinical StudyFrank G. Basile, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
